Prognostic factors in FIGO stage IB–IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study-Reference-Cited by-同舟云学术

Prognostic factors in FIGO stage IB–IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study

Published:2008-02 Issue:2 Volume:19 Page:321-326
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lee J.-M.,Lee K.-B.,Nam J.-H.,Ryu S.-Y.,Bae D.-S.,Park J.-T.,Kim S.-C.,Cha S.-D.,Kim K.-R.,Song S.-Y.,Kang S.-B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/2/321/723778/mdm465.pdf

Reference24 articles.

1. 2002 Annual Report of the Korea Central Cancer Registry (2002.1.–2002.12);Ministry of Health and Welfare,2003

2. Cervical cancer incidence and survival in Korea: 1993–2002;Chung;Int J Gynecol Cancer,2006

3. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence;Viswanathan;Gynecol Oncol,2004

4. Small cell carcinoma of the female genital tract;Crowder;Semin Oncol,2007

5. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis;Chan;Cancer,2003

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Cell Cervical Carcinoma in Pregnancy: Therapeutic Options for an Aggressive Cancer Diagnosis;American Journal of Perinatology Reports;2024-01

2. Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances;Biomedical Journal;2023-10

3. Neuroendocrine carcinoma of the cervix: About a rare case and literature review;International Journal of Surgery Case Reports;2023-10

4. Multimodal treatment for resectable neuroendocrine carcinoma of the cervix;Endocrine-Related Cancer;2023-07-10

5. The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry;The Lancet Oncology;2023-06